CSL (ASX:CSL) announces an acquisition
Jaz Harrison
June 9, 2020
CSL (ASX:CSL) has announced an acquisition to the market this
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL (ASX:CSL) has announced an acquisition to the market this
The S&P/ASX 200 (INDEXASX: XJO) is tipped to open slightly
Is the CSL (ASX:CSL) share price a buy after the
If you’re looking for the top ASX dividend income shares
Is CSL (ASX:CSL) the best COVID-19 recovery stock to buy
The latest of my “Never Sell stocks” is one of
The S&P/ASX 200 (ASX:XJO) has gone nuts in recent days.
Is the CSL (ASX: CSL) share price worth just $200?
The S&P/ASX 200 (ASX: XJO) finished the day trading at
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
